Akt–the Mammalian Target of Rapamycin (mTOR) Pathway Inhibition Increases Cervical Cancer Cell Chemosensitivity to Active Form of Irinotecan (SN-38). (2013). International Journal of Integrated Health Sciences, 1(1), 13-21. https://journal.fk.unpad.ac.id/index.php/ijihs/article/view/103